Improving care pathways for young colorectal cancer survivors
Official title: Risk stratified survivorship care pathways for early-onset colorectal cancer
Funded at University of Michigan at Ann Arbor · NIH-11039832 · Data updated 2026-11-12
This study is working to create personalized care plans for people under 50 who have survived early-onset colorectal cancer, so they can get the right follow-up care based on their specific needs and risks.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | March 21, 2023 |
| Project end | February 29, 2028 |
| Funding year | 2025 |
| Award (this year) | $619,593 |
| NIH project number | 5R37CA275907-03 |
| Project ID | NIH-11039832 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with stage I-III colorectal cancer before the age of 50.
✕Less likely to help
Patients diagnosed with colorectal cancer at age 50 or older may not benefit from this specific research.
What this research studies
This research focuses on developing tailored survivorship care pathways for individuals diagnosed with early-onset colorectal cancer, particularly those under 50 years old. By partnering with registries in Georgia, Kentucky, and Los Angeles County, the study aims to identify patterns of cancer recurrence and create population-level estimates of risk. The goal is to align the intensity of follow-up care with individual patient needs, ensuring that survivors receive high-quality, patient-centered care that addresses their unique challenges. This approach seeks to improve the overall quality of survivorship care for this vulnerable population.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized care for young colorectal cancer survivors, ultimately improving their health outcomes.
How similar studies have gone: Previous research has shown success in developing tailored care pathways for other cancer types, indicating potential for this novel approach in early-onset colorectal cancer.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Wallner, Lauren P — University of Michigan at Ann Arbor
- Study coordinator: Wallner, Lauren P
Related research
Other NIH-funded projects on the same topics.
-
Personalized follow-up plans for people diagnosed with colorectal cancer before age 50
This project will create tailored follow-up and support plans that match surveillance and services to the recurrence risk and needs of people diagnosed with colorectal cancer under 50.
-
Improving care for lung and colorectal cancer survivors through telehealth support
This study is looking to help people who have survived lung or colorectal cancer by offering them friendly support through online sessions with experienced nurses, so they can better manage their health and improve their quality of life after treatment.
-
Improving colorectal cancer screening and follow-up care.
This study is working to help more people get screened for colorectal cancer and receive the follow-up care they need, especially those who haven't been screened much before, so that everyone can have better access to important health checks and improve their overall health.
-
Understanding how survivorship care plans affect health outcomes for cancer survivors
A study will look at whether survivorship care plans help reduce deaths and improve health for adults who have survived cancer.
-
Colorectal cancer prognosis through a broad, collaborative study
A large, multi-center study follows people newly diagnosed with colorectal cancer to find biomarkers and patterns that predict outcomes and guide future care.
-
Ceramides and how they affect metabolism and colorectal cancer in adults
A study in adults with obesity-related health issues will explore how a fat-related molecule called ceramide influences metabolic problems and colorectal cancer risk.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.